Header Logo

Connection

Anny Xiang to Diabetes Mellitus, Type 2

Back to Details
This is a "connection" page, showing publications Anny Xiang has written about Diabetes Mellitus, Type 2.
Anny Xiang
Connection Strength
6.555
Diabetes Mellitus, Type 2
  1. Diabetes in Pregnancy for Mothers and Offspring: Reflection on 30 Years of Clinical and Translational Research: The 2022 Norbert Freinkel Award Lecture. Diabetes Care. 2023 03 01; 46(3):482-489.
    View in: PubMed
    Score: 0.483
  2. Maternal Gestational Diabetes and Type 2 Diabetes During Pregnancy and Risk of Childhood Asthma in Offspring. J Pediatr. 2020 04; 219:173-179.e1.
    View in: PubMed
    Score: 0.390
  3. Impact of Gastric Banding Versus Metformin on ß-Cell Function in Adults With Impaired Glucose Tolerance or Mild Type 2 Diabetes. Diabetes Care. 2018 12; 41(12):2544-2551.
    View in: PubMed
    Score: 0.356
  4. Longitudinal Increases in Adiposity Contribute to Worsening Adipokine Profile over Time in Mexican Americans. Obesity (Silver Spring). 2018 04; 26(4):703-712.
    View in: PubMed
    Score: 0.340
  5. Maternal Diabetes and Autism in Offspring--Reply. JAMA. 2015 Jul 28; 314(4):407.
    View in: PubMed
    Score: 0.285
  6. Association of maternal diabetes with autism in offspring. JAMA. 2015 Apr 14; 313(14):1425-34.
    View in: PubMed
    Score: 0.280
  7. Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes. J Clin Endocrinol Metab. 2015 Mar; 100(3):1187-95.
    View in: PubMed
    Score: 0.275
  8. High calorie intake is associated with worsening insulin resistance and ß-cell function in Hispanic women after gestational diabetes mellitus. Diabetes Care. 2014 Dec; 37(12):3294-300.
    View in: PubMed
    Score: 0.273
  9. Restoring Insulin Secretion (RISE): design of studies of ß-cell preservation in prediabetes and early type 2 diabetes across the life span. Diabetes Care. 2014; 37(3):780-8.
    View in: PubMed
    Score: 0.253
  10. Detailed physiological characterization of the development of type 2 diabetes in Hispanic women with prior gestational diabetes mellitus. Diabetes. 2010 Oct; 59(10):2625-30.
    View in: PubMed
    Score: 0.202
  11. Preventing type 2 diabetes with low-dose combinations. Lancet. 2010 Jul 10; 376(9735):72-4.
    View in: PubMed
    Score: 0.200
  12. Diabetes: preventing type 2 diabetes mellitus: is metformin the answer? Nat Rev Endocrinol. 2010 May; 6(5):253-4.
    View in: PubMed
    Score: 0.198
  13. Novel amino acid and fatty acid signatures linked to type 2 diabetes risk after gestational diabetes mellitus. Cardiovasc Diabetol. 2026 Apr 03; 25(1).
    View in: PubMed
    Score: 0.150
  14. Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes. Diabetes. 2006 Apr; 55(4):1074-9.
    View in: PubMed
    Score: 0.150
  15. Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus. Diabetes Care. 2006 Mar; 29(3):613-7.
    View in: PubMed
    Score: 0.149
  16. Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes. 2006 Feb; 55(2):517-22.
    View in: PubMed
    Score: 0.148
  17. Use of medications to prevent type 2 diabetes. Curr Diab Rep. 2005 Aug; 5(4):237-9.
    View in: PubMed
    Score: 0.143
  18. The association of weight status with glycemic control, diabetes related complications and anti-hyperglycemic medication use in patients with type 2 diabetes mellitus: The results of the Australian National Diabetes Audit (ANDA) 2015-2022. Diabetes Res Clin Pract. 2025 Aug; 226:112333.
    View in: PubMed
    Score: 0.142
  19. Large-scale multi-omics analyses in Hispanic/Latino populations identify genes for cardiometabolic traits. Nat Commun. 2025 Apr 11; 16(1):3438.
    View in: PubMed
    Score: 0.140
  20. Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in premenopausal women at high risk for type 2 diabetes. J Clin Endocrinol Metab. 2005 Apr; 90(4):1986-91.
    View in: PubMed
    Score: 0.137
  21. Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and beta-cell function. J Clin Endocrinol Metab. 2004 Jun; 89(6):2846-51.
    View in: PubMed
    Score: 0.132
  22. Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. Nature. 2024 Mar; 627(8003):347-357.
    View in: PubMed
    Score: 0.129
  23. Genome-wide association study and functional characterization identifies candidate genes for insulin-stimulated glucose uptake. Nat Genet. 2023 06; 55(6):973-983.
    View in: PubMed
    Score: 0.123
  24. Weight loss and ß-cell responses following gastric banding or pharmacotherapy in adults with impaired glucose tolerance or type 2 diabetes: a randomized trial. Obesity (Silver Spring). 2022 08; 30(8):1579-1588.
    View in: PubMed
    Score: 0.116
  25. Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nat Genet. 2022 May; 54(5):560-572.
    View in: PubMed
    Score: 0.114
  26. Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes. 1999 Apr; 48(4):848-54.
    View in: PubMed
    Score: 0.092
  27. Maternal Gestational Diabetes Mellitus, Type 1 Diabetes, and Type 2 Diabetes During Pregnancy and Risk of ADHD in Offspring. Diabetes Care. 2018 12; 41(12):2502-2508.
    View in: PubMed
    Score: 0.089
  28. Maternal Type 1 Diabetes and Risk of Autism in Offspring. JAMA. 2018 07 03; 320(1):89-91.
    View in: PubMed
    Score: 0.087
  29. A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants. Diabetes. 2017 08; 66(8):2296-2309.
    View in: PubMed
    Score: 0.081
  30. Improved Performance of Dynamic Measures of Insulin Response Over Surrogate Indices to Identify Genetic Contributors of Type 2 Diabetes: The GUARDIAN Consortium. Diabetes. 2016 07; 65(7):2072-80.
    View in: PubMed
    Score: 0.075
  31. Ambient Air Pollutants Have Adverse Effects on Insulin and Glucose Homeostasis in Mexican Americans. Diabetes Care. 2016 Apr; 39(4):547-54.
    View in: PubMed
    Score: 0.074
  32. Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium. Diabetes. 2015 May; 64(5):1853-66.
    View in: PubMed
    Score: 0.068
  33. Insulin sensitivity and insulin clearance are heritable and have strong genetic correlation in Mexican Americans. Obesity (Silver Spring). 2014 Apr; 22(4):1157-64.
    View in: PubMed
    Score: 0.065
  34. Systematic evaluation of validated type 2 diabetes and glycaemic trait loci for association with insulin clearance. Diabetologia. 2013 Jun; 56(6):1282-90.
    View in: PubMed
    Score: 0.061
  35. Evidence for sex-specific associations between variation in acid phosphatase locus 1 (ACP1) and insulin sensitivity in Mexican-Americans. J Clin Endocrinol Metab. 2009 Oct; 94(10):4094-102.
    View in: PubMed
    Score: 0.047
  36. Variation in IGF2BP2 interacts with adiposity to alter insulin sensitivity in Mexican Americans. Obesity (Silver Spring). 2009 Apr; 17(4):729-36.
    View in: PubMed
    Score: 0.045
  37. Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes. 2008 Apr; 57(4):1048-56.
    View in: PubMed
    Score: 0.042
  38. Effect of pioglitazone on progression of subclinical atherosclerosis in non-diabetic premenopausal Hispanic women with prior gestational diabetes. Atherosclerosis. 2008 Jul; 199(1):207-14.
    View in: PubMed
    Score: 0.042
  39. Genetics of gestational diabetes mellitus and type 2 diabetes. Diabetes Care. 2007 Jul; 30 Suppl 2:S134-40.
    View in: PubMed
    Score: 0.041
  40. Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) study. Diabetes Care. 2004 Jun; 27(6):1365-8.
    View in: PubMed
    Score: 0.033
  41. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes. 2002 Sep; 51(9):2796-803.
    View in: PubMed
    Score: 0.029
  42. Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes. 2000 May; 49(5):782-8.
    View in: PubMed
    Score: 0.025
  43. Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol. 2000 Feb; 182(2):313-20.
    View in: PubMed
    Score: 0.024
  44. Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes. 1999 Dec; 48(12):2430-6.
    View in: PubMed
    Score: 0.024
  45. Gestational diabetes mellitus, prenatal air pollution exposure, and autism spectrum disorder. Environ Int. 2019 12; 133(Pt A):105110.
    View in: PubMed
    Score: 0.024
  46. Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. JAMA. 1998 Aug 12; 280(6):533-8.
    View in: PubMed
    Score: 0.022
  47. Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes. 1998 Aug; 47(8):1302-10.
    View in: PubMed
    Score: 0.022
  48. TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus. Control Clin Trials. 1998 Apr; 19(2):217-31.
    View in: PubMed
    Score: 0.021
  49. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM. Diabetes. 1996 Nov; 45(11):1572-9.
    View in: PubMed
    Score: 0.019
  50. Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet. 1996 Jan 27; 347(8996):227-30.
    View in: PubMed
    Score: 0.018
  51. Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care. 1995 Nov; 18(11):1446-51.
    View in: PubMed
    Score: 0.018
  52. Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes. 1995 May; 44(5):586-91.
    View in: PubMed
    Score: 0.018
  53. The copper T380A intrauterine device in women with type II diabetes mellitus. Obstet Gynecol. 1994 Dec; 84(6):1006-9.
    View in: PubMed
    Score: 0.017
  54. Insulin clearance: confirmation as a highly heritable trait, and genome-wide linkage analysis. Diabetologia. 2012 Aug; 55(8):2183-92.
    View in: PubMed
    Score: 0.014
  55. Sequence variation in PPARG may underlie differential response to troglitazone. Diabetes. 2005 Nov; 54(11):3319-25.
    View in: PubMed
    Score: 0.009

© 2026 Kaiser Permanente

Your Privacy Choices